gentamicin has been researched along with 2019 Novel Coronavirus Disease in 4 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The antibacterial activity of poly (DABCO-BBAC) against eight multi drug resistant (MDR) Pseudomonas aeruginosa isolates from human burns, its possible synergistic effect with gentamicin, and the mechanism of action were examined." | 4.31 | Mechanism and antibacterial synergies of poly(Dabco-BBAC) nanoparticles against multi-drug resistant Pseudomonas aeruginosa isolates from human burns. ( Ebadati, A; Hajiebrahimdehi, AJ; Hamblin, MR; Karimi, M; Mahabadi, VP; Oshaghi, M; Parsa, P; Saeedi, S, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaiben, V | 1 |
| Yamada, CH | 1 |
| Telles, JP | 1 |
| de Andrade, AP | 1 |
| Arend, LNVS | 1 |
| Ribeiro, VST | 1 |
| Dantas, LR | 1 |
| Suss, PH | 1 |
| Tuon, FF | 1 |
| Ebadati, A | 1 |
| Oshaghi, M | 1 |
| Saeedi, S | 1 |
| Parsa, P | 1 |
| Mahabadi, VP | 1 |
| Karimi, M | 2 |
| Hajiebrahimdehi, AJ | 1 |
| Hamblin, MR | 1 |
| Gostyńska, A | 1 |
| Dettlaff, K | 1 |
| Jelińska, A | 1 |
| Stawny, M | 1 |
| Abu Lubad, MA | 1 |
| Abu-Helalah, MA | 1 |
| Al-Hajaia, TS | 1 |
| Al-Hutaibat, KA | 1 |
| Aqel, AA | 1 |
| Alzoubi, H | 1 |
4 other studies available for gentamicin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
A carbapenem-resistant Acinetobacter baumannii outbreak associated with a polymyxin shortage during the COVID pandemic: an in vitro and biofilm analysis of synergy between meropenem, gentamicin and sulbactam.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Biofilms; COVI | 2022 |
Mechanism and antibacterial synergies of poly(Dabco-BBAC) nanoparticles against multi-drug resistant Pseudomonas aeruginosa isolates from human burns.
Topics: Anti-Bacterial Agents; Burns; COVID-19; Gentamicins; Humans; Microbial Sensitivity Tests; Nanopartic | 2023 |
Improving the Safety of Clinical Management of COVID-19 Patients Receiving Aminoglycosides and Parenteral Nutrition: Y-site Compatibility Studies.
Topics: Aminoglycosides; Anti-Bacterial Agents; COVID-19; Gentamicins; Humans; Parenteral Nutrition; Tobramy | 2023 |
COVID-19 pandemic impact on antibiotics sensitivity of E. coli and K. pneumoniae from urine specimens: a retrospective study.
Topics: Anti-Bacterial Agents; Ceftriaxone; COVID-19; Escherichia coli; Gentamicins; Hospitals, Teaching; Hu | 2023 |